The main risk is not whether the battery works; it is whether Amprius can turn nominal capacity, trusted sourcing and strong evaluations into qualified, on-time, profitable volume. Supplier dependence, customer concentration and an already ambitious valuation mean the stock can
rerate sharply in either direction as each manufacturing and program gate is cleared or missed.